Work

Faculty Opinions recommendation of Phase 1 and pharmacokinetic study of lexatumumab in patients with advanced cancers.

Year: 2007

Type: peer-review

Source: Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

DOI: 10.3410/f.1092443.546879

Author: Robert Maki

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Cell death mechanisms and regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4205217524

Cites:

Cited by:

Related to: 10